Navigation Links
Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder

ptoms, or entirely separate symptom domains not mentioned in this analysis.

About Generalized Anxiety Disorder

Approximately 6.5 million Americans are diagnosed with generalized anxiety disorder each year.(4) Symptoms persist for at least six months and can include exaggerated worry or chronic anxiety, irritability, poor concentration, sleep disturbance and fatigue.(5,6) Generalized anxiety disorder may be brought on, or worsened by, stressful life events. The illness also tends to be chronic with periods of exacerbation and remission.(7)

About Cymbalta

Serotonin and norepinephrine in the brain and spinal cord are believed to both mediate core mood symptoms and help regulate the perception of pain. Based on pre-clinical studies, duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is believed to potentiate the activity of these chemicals in the central nervous system (brain and spinal cord). While the mechanism of action of duloxetine is not fully known, scientists believe its effects on depression and anxiety symptoms, as well as its effect on pain perception, may be due to increasing the activity of serotonin and norepinephrine in the central nervous system.

Cymbalta is approved in the United States for the treatment of major depressive disorder, the management of diabetic peripheral neuropathic pain and the treatment of generalized anxiety disorder, all in adults. Cymbalta is not approved for use in pediatric patients.

Important Safety Information

Cymbalta is approved to treat major depressive disorder, diabetic peripheral neuropathic pain and generalized anxiety disorder. In children and teens, antidepressants can increase the risk of suicidal thoughts or actions. Patients should call their doctor right away if they experience worsening depression symptoms, unusual changes in behavior or thoughts of suicide, especially at the beginning of treatment or after a change in dose.
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
(Date:12/19/2014)... 18, 2014 Baptist Health Lexington is the first ... receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status ... Atrial fibrillation is the most common cardiac arrhythmia and has ... can lead to stroke and possible death. More than 5 ... have atrial fibrillation and the numbers are rapidly increasing as ...
(Date:12/19/2014)... 2014   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... from its pivotal field study of AT-001 (Grapiprant), ... dogs with osteoarthritis.  In the study, dogs receiving ... were statistically significant compared to placebo (p<0.05) at ...
(Date:12/19/2014)... separating membrane market has witnessed robust development with ... albeit as a later starter. In 2012, the size of ... RMB12 billion, with the proportion worldwide soaring to 16.3%. It ... market will continue its growth rate by around 20% in ... jump to roughly RMB25 billion. An integrated membrane ...
Breaking Medicine Technology:Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3
... MELBOURNE, Fla. and BALTIMORE, March 15, 2011 ... venture to innovate, implement and commercialize next generation of ... brings together leading clinicians and advanced engineering technologists. ... ), an international communications and information technology company, and ...
... (Nasdaq: CPHD ) today announced that Glenn Steele, ... Board of Directors at the company,s Annual Meeting of Shareholders ... Steele has been President and Chief Executive Officer of Geisinger ... of Pennsylvania, since 2001.  Before that, Dr. Steele served as ...
Cached Medicine Technology:Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors 2Cepheid Announces Nomination of Geisinger Health System CEO and Renowned Oncology Researcher to Board of Directors 3
(Date:12/19/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief financial officer ... The top executive search firm in the healthcare industry, ... healthcare executives into organizations. , Johnson Memorial Hospital ... to the residents of Johnson County and the surrounding ...
(Date:12/19/2014)... If you have ever been unable to breathe, ... you had an arsenal of treatments to battle this ... breathing disorders. Currently, the only proven methods for controlling ... common treatments do exist. At the recent 2014 ... 34 asthma educators responded to a Harmonica Techs survey ...
(Date:12/19/2014)... Irving, Texas (PRWEB) December 19, 2014 ... recently exhibited at the AMSUS Society for Federal ... represent the locum tenens industry to military and ... Staffing attended the National Veterans Small Business Engagement ... “Locum Tenens continues to be a vital solution ...
(Date:12/19/2014)... By Amy Norton ... -- Children born to moms who were exposed to high ... increased risk of developing autism, a U.S. study suggests. ... birth between 1990 and 2002, those exposed to the most ... a baby who later developed autism. And exposure during the ...
(Date:12/17/2014)... While countless companies tempt patients to ... potential dangers of their purchase. Not only is the sale ... doctor, but patients who buy hCG online are typically receiving ... actually no real hCG present. Illegal internet hCG is typically ... safety standards and may contain unknown fillers that can pose ...
Breaking Medicine News(10 mins):Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 2Health News:Harmonica Techs, Inventors of the Pulmonica®, Unveil New Findings on Complementary Treatments for Asthma 3Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 2Health News:Diet Doc Reveals the Real Dangers for Those who Buy hCG Online 3
... ... nuts? It,s simple, with a new E-card from Snoring Isn,t Sexy®. Telling someone he or she ... a series of expletives. , ... 27, 2009 -- What,s the perfect way to tell a loved one that their snoring is ...
... , , , TOSU, Saga, ... 4530) and Hisamitsu U.S., Inc. today announced the completion of their ... of Northstar Merger Sub, Inc., a wholly owned subsidiary of Hisamitsu ... Pursuant to the Agreement and Plan of Merger among ...
... , THOUSAND OAKS, Calif., Aug. 27 The ... biggest breakthrough skin l a ser treatment ... . In Los Angeles, beautiful looking skin is a virtue that can ... flawless skin that cosmetic surgery is practically a must for individuals in ...
... drug might slow the destructive lung condition, studies show ... there is no cure for chronic obstructive pulmonary disease ... illness and add years to the lives of sufferers, ... disease of the lungs that is usually brought on ...
... , , , ... MPA Media today announced the launch of a new magazine in ... decisions. , , "MPA Media is fortunate ... by more and more consumers. The most recent research shows that ...
... , , 31 Attorneys General ... , WASHINGTON, Aug. 27 The American Health Care ... letter to Health and Human Services Secretary Kathleen Sebelius, calling for ... Services (CMS,) Nursing Home Five Star Rating System. , ...
Cached Medicine News:Health News:Snoring Isn't Sexy, LLC Announces the Launch of E-cards for Snorers 2Health News:Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals 2Health News:Los Angeles Clinic (laserandveinclinic.com) Offers the Latest Laser Skin Rejuvenation Treatments 2Health News:Treating COPD Early Improves Outcomes 2Health News:Treating COPD Early Improves Outcomes 3Health News:Treating COPD Early Improves Outcomes 4Health News:MPA Media Launches New Chiropractic Publication, Dynamic Chiropractic PracticeINSIGHTS 2Health News:CMS' Five Star Nursing Home Rating System Called Into Question Once Again 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: